CAS: 62306-79-0; (5-Methylfuran-2-yl)Boronic Acid

2-甲基呋喃 反应生成 5-甲基呋喃-2-硼酸
参考文献: Triazolo [4,5-D] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists[fr] Dérivés De Triazalo [4,5-D] Pyramidine Et Leur Utilisation Comme Antagonistes Des Récepteurs De La Purine
标题: Triazolo [4,5-D] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists[fr] Dérivés De Triazalo [4,5-D] Pyramidine Et Leur Utilisation Comme Antagonistes Des Récepteurs De La Purine
摘要:公式(i)的化合物能够作为嘌呤受体拮抗剂发挥作用,包括这些化合物的制药组合物以及制备这些化合物的方法.这些化合物和组合物可用于治疗或预防与嘌呤受体过度功能相关的疾病.

专利信息

专利号:WO-03061385-A1
优先权日:2002-01-17
标题:Tricyclic nucleoside library compounds, synthesis, and use as antiviral agents
发明人：AN HAOYUN; HONG ZHI; SMITH KENNETH; DING YILI; GIRARDET JEAN-LUC
权利人:RIBAPHARM INC; AN HAOYUN; HONG ZHI; SMITH KENNETH; DING YILI; GIRARDET JEAN-LUC
摘要:Tricyclic nucleoside libraries and library compounds are prepared using combinatorial chemistry and non-combinatorial chemistry methods. Contemplated library compounds are particularly useful in inhibition of viral propagation, and particularly of viral propagation of the HCV virus.

专利号:WO-2023057548-A1
优先权日:2021-10-07
标题:Ccr6 receptor modulators
发明人：AISSAOUI HAMED; ALLEMANN OLIVER; CAROFF EVA; MEYER EMMANUEL; RICHARD-BILDSTEIN SYLVIA
权利人:IDORSIA PHARMACEUTICALS LTD
摘要:The present invention relates to compounds of Formula (I), their synthesis and use as CCR6 receptor modulators for the prevention or treatment of e.g. inflammatory/autoimmune diseases/disorders and cancer.

专利号:US-9951062-B2
优先权日:2012-12-14
标 题 :Substituted 1 H-pyrrolo [2, 3-b] pyridine and 1 H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
发明人：VANKAYALAPATI HARIPRASAD; YERRAMREDDY VENKATAKRISHNAREDDY; GANIPISETTY VENU BABU; TALLURI SURESHKUMAR; APPALANENI RAJENDRA P
权利人:ARRIEN PHARMACEUTICALS LLC
摘要:Compounds according to Formulas I, IA or IB: n nto pharmaceutically acceptable composition, salts thereof, their synthesis and their use as SIK2 inhibitors including such compounds and methods of using said compounds in the treatment of various diseases and/or disorders such as cancer, stroke, cardiovascular, obesity and type II diabetes.